Arcoma Aktiebolag has announced an extra general meeting scheduled for 9 December 2026 in Stockholm. The board is seeking shareholder authorization to acquire or transfer up to 10% of the company's total shares to optimize capital structure and facilitate future strategic investments.
The board convenes an extra general meeting on 9 December 2026 to seek shareholder authorization to buy back or sell own shares of up to 10% of all shares. This is an enabling mandate, not a committed buyback, and no repurchase amount or price target is announced, so the direct price effect is limited. Such routine authorizations are common and largely expected by the market.
- • Extra general meeting on 9 December 2026 to vote on a share buyback/sale authorization covering up to 10% of shares
- • The mandate is only a proposal requiring a two-thirds majority at the meeting
- • No commitment or size for actual share repurchases is stated